AstraZeneca to divest Rhinocort Aqua rights outside US

10-10-2016

AstraZeneca to divest Rhinocort Aqua rights outside US

Rawpixel.com / Shutterstock, Inc

AstraZeneca and Cilag, an affiliate of Johnson & Johnson, have entered into an agreement for AstraZeneca to divest the rights to Rhinocort Aqua (budesonide) outside the US.


AstraZeneca, Cilag, Johnson & Johnson, Rhinocort Aqua, divestiture, budesonide

LSIPR